GFR alpha-1

GFR alpha-1

GFR alpha-1 Informations sur la molécule

Molecule Name
Glial cell line-derived neurotrophic factor receptors
Alias de la molécule
GFRA1,GDNFRA,RETL1,TRNR1,GDNFR,GFR-ALPHA-1,RET1L
Drug Development Progress
Nombre de médicaments cliniques3
Nombre de médicaments commercialisés0
Phase de R&D la plus avancéePhase 2 Clinical
Alias de la cible
Glial Cell Line-Derived Neurotrophic Factor Receptors
Contexte de la molécule
GDNF family receptor alpha-1 (GFRA1) is also known as RET ligand 1 (RETL1), TGF-beta-related neurotrophic factor receptor 1 (TRNR1), is a novel glycosylphosphatidylinositol (GPI)-linked cell surface receptor, and belongs to the glial cell line-derived neurotrophic factor (GDNF) receptor subfamily. The GDNF family ligands comprises GDNF, Neurturin (NTN), Artemin, and Persephin. GDNF and NTN are two structurally related, potent neurotrophic factors that play key roles in the control of neuron survival and differentiation. GFRA1 mediates the association with and activation of the RET tyrosine kinase receptor (RTK), and subsequently initiates the RET signaling pathway. GFR alpha-mediated signaling plays an important role in the survival, differentiation, and migration of central and peripheral neurons, and is essential for the development of kidneys and the enteric nervous system, as well as the inflammatory response in some carciniomas.

GFR alpha-1 Liste de produits

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
KLS-2031KLS-2031Phase 2 ClinicalKolon Life Science. Inc
Neuralgia; Radiculopathy
Details
NGM-386NGM-386Phase 1 ClinicalNGM Biopharmaceuticals Inc
Obesity
Details
NGM-395NGM-395Phase 1 ClinicalNGM Biopharmaceuticals Inc
Metabolic Dysfunction-Associated Steatotic Liver Disease; Obesity
Details